This finding did not reach statistical significance and adverse effects were dose-related. 37 A dose-finding study of escitalopram in nonresistant OCD suggested a dose-response effect with 20 mg daily which was numerically more robust than 10 mg daily on some secondary measures. 38 There were no significant adverse event differences between the two dosage groups.
1
—
—